Page last updated: 2024-11-05

thalidomide and Diplopia

thalidomide has been researched along with Diplopia in 2 studies

Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.

Diplopia: A visual symptom in which a single object is perceived by the visual cortex as two objects rather than one. Disorders associated with this condition include REFRACTIVE ERRORS; STRABISMUS; OCULOMOTOR NERVE DISEASES; TROCHLEAR NERVE DISEASES; ABDUCENS NERVE DISEASES; and diseases of the BRAIN STEM and OCCIPITAL LOBE.

Research Excerpts

ExcerptRelevanceReference
"Plasmacytomas are monoclonal plasma cell tumors."1.42Diplopia and variable ptosis as the sole initial findings in a case of orbital plasmacytoma and multiple myeloma. ( Galea, M; McMillan, N; Weir, C, 2015)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Galea, M1
McMillan, N1
Weir, C1
Katodritou, E1
Speletas, M1
Pouli, A1
Tsitouridis, J1
Zervas, K1
Terpos, E1

Other Studies

2 other studies available for thalidomide and Diplopia

ArticleYear
Diplopia and variable ptosis as the sole initial findings in a case of orbital plasmacytoma and multiple myeloma.
    Seminars in ophthalmology, 2015, Volume: 30, Issue:3

    Topics: Antineoplastic Agents, Alkylating; Biopsy; Blepharoptosis; Bone Marrow Cells; Cyclophosphamide; Dexa

2015
Successful treatment of extramedullary plasmacytoma of the cavernous sinus using a combination of intermediate dose of thalidomide and dexamethasone.
    Acta haematologica, 2007, Volume: 117, Issue:1

    Topics: Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Cavernous Sinus; Dexamethas

2007